1. Home
  2. UPB vs ADSE Comparison

UPB vs ADSE Comparison

Compare UPB & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPB
  • ADSE
  • Stock Information
  • Founded
  • UPB 2021
  • ADSE 1980
  • Country
  • UPB United States
  • ADSE Ireland
  • Employees
  • UPB N/A
  • ADSE N/A
  • Industry
  • UPB
  • ADSE Industrial Specialties
  • Sector
  • UPB
  • ADSE Consumer Discretionary
  • Exchange
  • UPB NYSE
  • ADSE Nasdaq
  • Market Cap
  • UPB 521.3M
  • ADSE 603.2M
  • IPO Year
  • UPB 2024
  • ADSE N/A
  • Fundamental
  • Price
  • UPB $10.93
  • ADSE $13.54
  • Analyst Decision
  • UPB Strong Buy
  • ADSE
  • Analyst Count
  • UPB 4
  • ADSE 0
  • Target Price
  • UPB $56.50
  • ADSE N/A
  • AVG Volume (30 Days)
  • UPB 411.4K
  • ADSE 96.0K
  • Earning Date
  • UPB 08-14-2025
  • ADSE 05-12-2025
  • Dividend Yield
  • UPB N/A
  • ADSE N/A
  • EPS Growth
  • UPB N/A
  • ADSE N/A
  • EPS
  • UPB N/A
  • ADSE N/A
  • Revenue
  • UPB $2,296,000.00
  • ADSE $113,896,884.00
  • Revenue This Year
  • UPB N/A
  • ADSE $219.58
  • Revenue Next Year
  • UPB N/A
  • ADSE N/A
  • P/E Ratio
  • UPB N/A
  • ADSE N/A
  • Revenue Growth
  • UPB N/A
  • ADSE 2.45
  • 52 Week Low
  • UPB $5.14
  • ADSE $9.00
  • 52 Week High
  • UPB $29.46
  • ADSE $16.35
  • Technical
  • Relative Strength Index (RSI)
  • UPB N/A
  • ADSE 60.83
  • Support Level
  • UPB N/A
  • ADSE $11.61
  • Resistance Level
  • UPB N/A
  • ADSE $13.06
  • Average True Range (ATR)
  • UPB 0.00
  • ADSE 0.85
  • MACD
  • UPB 0.00
  • ADSE 0.34
  • Stochastic Oscillator
  • UPB 0.00
  • ADSE 90.51

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.

About ADSE ADS-TEC ENERGY PLC

ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: